Dublin-based Neuromod has raised €10.5m and plans to further fuel Lenire's commercialisation in Europe and reach US veterans.
Medical Device Network on MSN3d
Neuromod secures €10m to expand tinnitus treatment device’s availabilityNeuromod Devices has secured €10m ($10.8m) in equity financing to broaden the reach of Lenire, its treatment device.
3d
Irish medtech group Neuromod Devices has raised €10 million equity financing to expand the availability of its tinnitus ...
Neuromod Devices announced today that it closed an equity financing round worth proceeds of about $10.9 million (€10 million) ...
Irish Examiner on MSN3d
Irish med device expands its tinnitus treatment for US military vetsNeuromod has closed a €10m round of equity financing as it looks to expand the availability of its tinnitus treatment device ...
Independent.ie on MSN2d
‘We’re very much an Irish story all the way’ – Neuromod raises €10m to expand its tinnitus treatmentIrish medtech company Neuromod has raised €10m in equity financing to expand the production of Lenire – a device that helps ...
Neuromod Devices Ltd. (Neuromod), an Irish medical device company specialising in tinnitus, has successfully closed a ?10 million equity financing to expand the availability of its tinnitus treatment ...
In June 2024, Neuromod was awarded a Federal Supply Schedule 65 II Medical Equipment and Supply Contract from the US Government, making Lenire a treatment option for the 2.9 million US Veterans ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback